Science Explorer Back to mapMap
Discussion
Company · Haarlem · Netherlands

Teva Pharmaceuticals (Netherlands)

Research works
69
▲ 42% vs 2018-21
Citations
633
9.1 per fractional work
Top-10% rate
11.6%
all institutions 10.0%
Open access
42%
world 40%
International
72%
world 18%

Not ranked overall: Teva Pharmaceuticals (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Teva Pharmaceuticals (Netherlands) work in?

In 2022-now, 63% of research at Teva Pharmaceuticals (Netherlands) is in Health Sciences, 13% in Social Sciences. Its largest fields are Medicine (62%), Engineering (10%), Social Sciences (9%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 63.2% of its workMedicine: 14 fractional works · 62.0% of its workPsychiatry and Mental health: 6 fractional works · 26.8% of its workPulmonary and Respiratory Medicine: 3 fractional works · 11.9% of its workPhysiology: 1 fractional works · 5.2% of its workOncology: 1 fractional works · 3.7% of its workNeurology: 1 fractional works · 3.1% of its workPathology and Forensic Medicine: 0 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.5% of its workEpidemiology: 0 fractional works · 1.2% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workFamily Practice: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.1% of its workOccupational Therapy: 0 fractional works · 0.7% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.2% of its workSocial Sciences: 3 fractional works · 12.7% of its workSocial Sciences: 2 fractional works · 8.8% of its workLaw: 1 fractional works · 5.0% of its workEducation: 1 fractional works · 2.9% of its workSociology and Political Science: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 2.1% of its workClinical Psychology: 0 fractional works · 1.6% of its workSocial Psychology: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.7% of its workAccounting: 0 fractional works · 0.7% of its workPhysical Sciences: 3 fractional works · 12.4% of its workEngineering: 2 fractional works · 9.6% of its workBiomedical Engineering: 2 fractional works · 8.1% of its workMechanical Engineering: 0 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.3% of its workOcean Engineering: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 1.3% of its workArtificial Intelligence: 0 fractional works · 0.6% of its workComputer Graphics and Computer-Aided Design: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 0 fractional works · 0.7% of its workInorganic Chemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workGeology: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.3% of its workBiomaterials: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.2% of its workLife Sciences: 3 fractional works · 11.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 5.0% of its workMolecular Biology: 1 fractional works · 2.4% of its workGenetics: 0 fractional works · 2.2% of its workBiotechnology: 0 fractional works · 0.5% of its workNeuroscience: 1 fractional works · 3.8% of its workNeurology: 1 fractional works · 2.2% of its workCognitive Neuroscience: 0 fractional works · 1.1% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workImmunology: 0 fractional works · 1.0% of its workVirology: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.3% of its workALL ITS WORKTevaPharmaceuticals…23fractional works, 2022-now
Life Sciences12%Physical Sciences12%Health Sciences63%Social Sciences13%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine1462.0%
    2. Health Professions01.1%
    1. Social Sciences28.8%
    2. Psychology02.1%
    3. Economics, Econometrics and Finance01.1%
    4. Business, Management and Accounting00.7%
    1. Engineering29.6%
    2. Computer Science01.3%
    3. Chemistry00.7%
    4. Earth and Planetary Sciences00.3%
    5. Materials Science00.3%
    6. Mathematics00.2%
    1. Biochemistry, Genetics and Molecular Biology15.0%
    2. Neuroscience13.8%
    3. Immunology and Microbiology01.5%
    4. Pharmacology, Toxicology and Pharmaceutics01.1%
    5. Agricultural and Biological Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.94× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.45× its world share, 0 worksImmunology and Micro…Neuroscience: 2.36× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.17× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.46× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.23× its world share, 0 worksEarth and Planetary …Engineering: 0.64× its world share, 2 worksEngineeringMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 0.15× its world share, 0 worksMathematicsHealth Professions: 0.43× its world share, 0 worksHealth ProfessionsMedicine: 3.23× its world share, 14 worksMedicineBusiness, Management and Accounting: 0.22× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.50× its world share, 0 worksEconomics, Econometr…Psychology: 0.68× its world share, 0 worksPsychologySocial Sciences: 0.69× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Medicine3.23×14 works
  2. Pharmacology, Toxicology and Pharmaceutics3.17×0 works
  3. Neuroscience2.36×1 works
  4. Immunology and Microbiology1.45×0 works
  5. Biochemistry, Genetics and Molecular Biology0.94×1 works
  6. Social Sciences0.69×2 works
  7. Psychology0.68×0 works
  8. Engineering0.64×2 works
  9. Economics, Econometrics and Finance0.50×0 works
  10. Chemistry0.46×0 works
  11. Health Professions0.43×0 works
  12. Earth and Planetary Sciences0.23×0 works
  13. Business, Management and Accounting0.22×0 works
  14. Computer Science0.17×0 works
  15. Mathematics0.15×0 works
  16. Materials Science0.07×0 works
  17. Agricultural and Biological Sciences0.06×0 works

Who are the top researchers at Teva Pharmaceuticals (Netherlands)?

Ranked on the quality score, GUILHERME G SAFIOTI, Maurice T. Driessen and Tanisha D. Hill lead among researchers whose main affiliation is Teva Pharmaceuticals (Netherlands).

  1. 1 GUILHERME G SAFIOTI Netherlands · #1,566,252 worldwide 717 citations · 61 works
  2. 2 Maurice T. Driessen Netherlands · #1,619,310 worldwide 1.4k citations · 65 works
  3. 3 Tanisha D. Hill Netherlands · #1,884,910 worldwide 407 citations · 35 works
  4. 4 Jan Bron Netherlands · #4,850,447 worldwide 288 citations · 43 works
  5. 5 A. Plich Netherlands · #4,871,774 worldwide 209 citations · 37 works
  6. 6 Saku Torvinen Netherlands · #5,370,065 worldwide 794 citations · 76 works
All ranked researchers at Teva Pharmaceuticals (Netherlands)

What are the most cited papers from Teva Pharmaceuticals (Netherlands)?

The most cited paper from Teva Pharmaceuticals (Netherlands) is "Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial" (Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al., 2019), with 445 citations. Next come "Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling" (354) and "Digital technologies and adherence in respiratory diseases: the road ahead" (144).

Most cited papers
#PaperReleasedCitations
1 Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al. · The Lancet 16 Aug 2019 445
2 Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling Gerty Schreibelt, Gijs Kooij, Arie Reijerkerk et al. · The FASEB Journal 22 Jun 2007 354
3 Digital technologies and adherence in respiratory diseases: the road ahead John Blakey, Bruce G. Bender, Alexandra Lelia Dima et al. · European Respiratory Journal Open access Nov 2018 144
4 Digital Health Technology in Asthma: A Comprehensive Scoping Review Giselle S Mosnaim, GUILHERME G SAFIOTI, Randall W. Brown et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 27 Feb 2021 120
5 The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries Adam P Lewis, Saku Torvinen, P.N.R. Dekhuijzen et al. · BMC Health Services Research Open access 12 Jul 2016 102
All 60 most cited papers, with filters and sorting

Which keywords describe research at Teva Pharmaceuticals (Netherlands)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Neurological Disorders, Migraine, Calcitonin Gene-Related Peptide, Headache Disorders, Inhaler Devices, Pulmonary Drug Delivery, Nanoparticles and Genetics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Neurological Disorders5▲ 41×6 topics
  2. Migraine5▲ 501×2 topics
  3. Calcitonin Gene-Related Peptide5▲ 488×1 topic
  4. Headache Disorders5▲ 841×1 topic
  5. Epidemiology2▲ 2.0×9 topics
  6. Nanoparticles2▲ 5.7×2 topics
  7. Inhaler Devices2▲ 272×1 topic
  8. Pulmonary Drug Delivery2▲ 272×1 topic
  9. Inflammation2▲ 3.0×5 topics
  10. Treatment1▲ 5.0×5 topics
  11. Genetics1▲ 8.0×4 topics
  12. Cancer Treatment1▲ 19×2 topics
  13. Drug Delivery1▲ 8.5×2 topics
  14. Blood-Brain Barrier1▲ 67×1 topic
  15. Focused Ultrasound1▲ 184×1 topic

Which research topics does Teva Pharmaceuticals (Netherlands) publish most on?

By volume in 2022-now: Migraine and Headache Studies, Inhalation and Respiratory Drug Delivery, Ultrasound and Hyperthermia Applications and Asthma and respiratory diseases.

  1. 1 Migraine and Headache Studies Psychiatry and Mental health 5 works
  2. 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 2 works
  3. 3 Ultrasound and Hyperthermia Applications Biomedical Engineering 1 works
  4. 4 Asthma and respiratory diseases Physiology 1 works
  5. 5 Dutch Social and Cultural Studies Education 1 works
  6. 6 Comparative and International Law Studies Law 1 works
  7. 7 Photoacoustic and Ultrasonic Imaging Biomedical Engineering 1 works
  8. 8 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  9. 9 Neurological Complications and Syndromes Psychiatry and Mental health 0 works
  10. 10 Criminal Law and Evidence Law 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.3%not open57.7%

World: 40% of research is openly available.

with international co-authors71.7%domestic only28.3%

World: 18% is written across borders.

How has Teva Pharmaceuticals (Netherlands)'s research output changed?

Output in 2022-2025 was 42% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Teva Pharmaceuticals (Netherlands) as a percentage of every work published that year, 0.00010% in 2024.

still counting0.00010%0.00020%0.00030%Teva Pharmaceuticals (Netherlands)0.000042% in 20251990200020102020

Fractional works of Teva Pharmaceuticals (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Haarlem

All research institutions in Haarlem

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Teva Pharmaceuticals (Netherlands). Posts are plain text and can be reported.